Kamunkhwala Gausi
12PUBLICATIONS
59CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (12)
Sort by Publication Date:
|Jan 07, 2026
PET/CT imaging of tuberculosis lung lesions in marmosets treated with different drug regimens aligns with human clinical outcomes.Talia Greenstein, Laura E Via, Mariana Pereira Moraes
|Oct 24, 2025
Insights into the Role of Rifampicin Exposure and Clinical Baseline Covariates on the Response to Pulmonary Tuberculosis Treatment.Marie Wijk, Paolo Denti, Kamunkhwala Gausi
|Apr 28, 2025
Population Pharmacokinetics of Rifampicin in Plasma and Cerebrospinal Fluid in Adults With Tuberculosis Meningitis.Noha Abdelgawad, Sean Wasserman, Kamunkhwala Gausi
|Mar 10, 2025
Exposure-tumour growth inhibition modelling of brigimadlin using phase I solid tumour data to support phase II dose selection.Ida Neldemo, Kamunkhwala Gausi, Céline Sarr
|Feb 01, 2025
Intracellular Penetration of Atazanavir, Ritonavir and Dolutegravir With Concomitant Rifampicin: A Dose Escalation Study.Amedeo De Nicolò, Alice Palermiti, Henry Mugerwa
|Jul 10, 2024
The impact of alcohol and illicit substance use on the pharmacokinetics of first-line TB drugs.Marie Wijk, Kamunkhwala Gausi, Samantha Malatesta
Pageof 2
Frequent Collaborators
9 joint publications
Paolo Denti
5 joint publications
Lubbe Wiesner
3 joint publications
Helen McIlleron
2 joint publications
Frank Kloprogge
2 joint publications
Amedeo De Nicolò
2 joint publications
Gary Maartens
2 joint publications
C Robert Horsburgh
2 joint publications
Marie Wijk
1 joint publications
Bree B Aldridge
1 joint publications
Maxwell Chirehwa
